跳至主要内容

Anti-Inflammatory Efficacy of Product Containing “Skin Calm Complex” in Vitro Reconstructed Epidermis

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51336#.VGR0KGfHRK0

Atopic dermatitis is classified as a chronic inflammatory skin disease, which is characterized by alterations in barrier function and immune system of the skin. In a previous study, the efficacy of REPAVAR ATOPIC SKIN BODY CREAM EXTREME (a product containing “SKIN CALM COMPLEX”) on the epidermal barrier structure was demonstrated. However, the product has also been formulated to improve inflammation and itching. The aim of this study is to analyze product effectiveness on skin inflammation and itching which is associated with atopic dermatitis, by quantification of IL-1α and IL-8 interleukins secreted by human keratinocytes from reconstructed epidermis by ELISA assay. Mature (aged 17 days) sample tissues were treated with pro-inflammatory agents (PBS 1X and LPS) and with the product containing synergistic mix from plants extracts and Dihydroavenanthramide D, among other ingredients (“SKIN CALM COMPLEX”) for 24 hours. Measuring the amounts of interleukins by ELISA assay showed 1) decreased levels of IL-1α and 2) no differences about IL-8 secretion. Product REPAVAR ATOPIC SKIN BODY CREAM EXTREME has an anti-inflammatory effect on the release of pro-inflammatory cytokines, becoming an effective preventive agent on inflammation and itching due to maintenance and improvement of the keratinocyte epidermal structure.
Cite this paper
Yzaguirre, M. , Bacchini, G. , Luna, E. and Vila-Martínez, E. (2014) Anti-Inflammatory Efficacy of Product Containing “Skin Calm Complex” in Vitro Reconstructed Epidermis. Journal of Cosmetics, Dermatological Sciences and Applications, 4, 309-315. doi: 10.4236/jcdsa.2014.45040. 
 

[1] Boguniewicz, M. and Leung, D.Y. (2011) Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation. Immunological Reviews, 242, 233-246.
http://dx.doi.org/10.1111/j.1600-065X.2011.01027.x
[2] Kasraie, S. and Werfel, T. (2013) Role of Macrophages in the Pathogenesis of Atopic Dermatitis. Mediators of Inflammation, 2013, 1-15. http://dx.doi.org/10.1155/2013/942375
[3] Segre, J.A. (2006) Epidermal Barrier Formation and Recovery in Skin Disorders. The Journal of Clinical Investigation, 116, 1150-1158. http://dx.doi.org/10.1172/JCI28521
[4] Jensen, L.E. (2010) Targeting the IL-1 Family Members in Skin Inflammation. Current Opinion in Investigational Drugs, 11, 1211-1220.
[5] Engelhart, K., El Hindi, T., Biesalski, H.K. and Pfitzner, I. (2005) In Vitro Reproduction of Clinical Hallmarks of Eczematous Dermatitis in Organotypic Skin Models. Archives of Dermatological Research, 297, 1-9.http://dx.doi.org/10.1007/s00403-005-0575-7
[6] Tivoli, Y.A. and Rubenstein, R.M. (2009) Pruritus: An Updated Look at an Old Problem. Journal of Clinical and Aesthetic Dermatology, 2, 30-36.
[7] Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E. and Bíró, T. (2006) Neurophysiological, Neuroimmunological, and Neuroendocrine Basis of Pruritus. Journal of Investigative Dermatology, 126, 1705-1718.http://dx.doi.org/10.1038/sj.jid.5700231
[8] Pastar, Z., Lipozencic, J. and Ljubojevic, S. (2005) Etiopathogenesis of Atopic Dermatitis—An Overview. Acta Dermatovenerologica Croatica, 13, 54-62.
[9] Polo, N. (2003) Dermatitis atópica. JANO, 1.475, 42-44.
[10] Novak, N. and Leung, D.Y. (2011) Advances in Atopic Dermatitis. Current Opinion in Immunology, 23, 778-783.http://dx.doi.org/10.1016/j.coi.2011.09.007
[11] Elias, P.M. (2010) Therapeutic Implications of a Barrier-Based Pathogenesis of Atopic Dermatitis. Annals of Dermatology, 22, 245-254. http://dx.doi.org/10.5021/ad.2010.22.3.245
[12] Ballona, R. and Ballona, C. (2004) Dermatitis atópica. Folia Dermatológica Peruana, 15, 40-48.
[13] Theoharides, T.C., Alysandratos, K.D., Angelidou, A., Delivanis, D.A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A. and Kalogeromitros, D. (2012) Mast Cells and Inflammation. Biochimica et Biophysica Acta, 1822, 21-33.
[14] Elias, P.M. and Schmuth, M. (2009) Abnormal Skin Barrier in the Etiopathogenesis of Atopic Dermatitis. Current Allergy and Asthma Reports, 9, 265-272.
http://dx.doi.org/10.1007/s11882-009-0037-y
[15] Komine, M. (2009) Analysis of the Mechanism for the Development of Allergic Skin Inflammation and the Application for Its Treatment: Keratinocytes in Atopic Dermatitis—Their Pathogenic Involvement. Journal of Pharmacological Sciences, 110, 260-264. http://dx.doi.org/10.1254/jphs.09R06FM
[16] Klein, P.A. and Clark, R.A. (1999) An Evidence-Based Review of the Efficacy of Antihistamines in Relieving Pruritus in Atopic Dermatitis. JAMA Dermatology, 135, 1522-1525.
http://dx.doi.org/10.1001/archderm.135.12.1522
[17] Brandt, E.B. and Sivaprasad, U. (2011) Th2 Cytokines and Atopic Dermatitis. Journal of Clinical & Cellular Immunology, 2, 110-123. http://dx.doi.org/10.4172/2155-9899.1000110
[18] Sonkoly, E., Muller, A., Lauerma, A.I., Pivarcsi, A., Soto, H., Kemeny, L., Alenius, H., Dieu-Nosjean, M.C., Meller, S., Rieker, J., Steinhoff, M., Hoffmann, T.K., Ruzicka, T., Zlotnik, A. and Homey, B. (2006) IL-31: A New Link between T Cells and Pruritus in Atopic Skin Inflammation. Journal of Allergy and Clinical Immunology, 117, 411-417. http://dx.doi.org/10.1016/j.jaci.2005.10.033
[19] http://www.skinethic.com/RHE.asp
[20] Merlin, J.L., Azzi, S., Lignon, D., Ramacci, C., Zeghari, N. and Guillemin, F. (1992) MTT Assays Allow Quick and Reliable Measurement of the Response of Human Tumour Cells to Photodynamic Therapy. European Journal of Cancer, 28, 1452-1458. http://dx.doi.org/10.1016/0959-8049(92)90542-A
[21] Matabuena-de Yzaguirre, M., Bacchini, G., Vila-Martínez, E. and Juarranz, A. (2014) Product Containing “Skin Calm Complex” Improves Barrier Effect in Vitro. Journal of Cosmetics, Dermatological Sciences and Applications, 4, 234-243. http://dx.doi.org/10.4236/jcdsa.2014.44032
[22] Venge, P. (1993) Eosinophil and Neutrophil Granulocytes. Allergy, 48, 39-47.
http://dx.doi.org/10.1111/j.1398-9995.1993.tb04697.x
[23] Hong, J., Buddenkotte, J., Berger, T.G. and Steinhoff, M. (2011) Management of Itch in Atopic Dermatitis. Seminars in Cutaneous Medicine and Surgery, 30, 71-86.
http://dx.doi.org/10.1016/j.sder.2011.05.002
[24] Lee, J., Jung, E., Park, B., Jung, K., Park, J., Kim, K., Kim, K.H. and Park, D. (2005) Evaluation of the Anti-Inflammatory and Atopic Dermatitis-Mitigating Effects of BSASM, a Multicompound Preparation. Journal of Ethnopharmacology, 96, 211-219. http://dx.doi.org/10.1016/j.jep.2004.09.012
[25] Sur, R., Nigam, A., Grote, D., Liebel, F. and Southall, M.D. (2008) Avenanthramides, Polyphenols from Oats, Exhibit Anti-Inflammatory and Anti-Itch Activity. Archives of Dermatological Research, 300, 569-574. http://dx.doi.org/10.1007/s00403-008-0858-x
[26] Albanesi, C., Scarponi, C., Giustizieri, M.L. and Girolomoni, G. (2005) Keratinocytes in Inflammatory Skin Diseases. Current Drug Target-Inflammation & Allergy, 4, 329-334.
http://dx.doi.org/10.2174/1568010054022033                 eww141113lx
[27] Uchiyama, N., Yamamoto, A., Kameda, K., Yamaguchi, H. and Ito, M. (2000) The Activity of Fatty Acid Synthase of Epidermal Keratinocytes Is Regulated in the Lower Stratum Spinousum and the Stratum Basale by Local Inflammation Rather than by Circulating Hormones. Journal of Dermatological Science, 24, 134-141. http://dx.doi.org/10.1016/S0923-1811(00)00088-8
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文